20-HETE contributes to ischemia-induced angiogenesis

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Physiology

Background:

• Angiogenesis is vital for peripheral ischemia recovery.
• The role of 20-hydroxyeicosatetraenoic acid (20-HETE) in ischemia-induced angiogenesis requires elucidation.

Purpose of the Study:

• To investigate the contribution of 20-HETE to ischemia-induced angiogenesis.
• To explore the molecular and cellular mechanisms underlying 20-HETE's role in this process.

Main Methods:

• Mouse hindlimb ischemia model.
• Laser Doppler Perfusion Imaging for blood flow assessment.
• CD31 and tomato lectin staining for microvessel density.
• LC/MS/MS for 20-HETE quantification.
• Immunofluorescence for CYP4A12, HIF-1α, VEGF, VEGFR2, and ERK1/2 expression analysis.

Main Results:

• Inhibitors of 20-HETE synthesis (DDMS) and action (6,15-20-HEDGE) reduced blood flow recovery and microvessel formation.
• Ischemia increased 20-HETE production and CYP4A12 expression in muscles, with CYP4A12 localized to endothelial cells.
• Ischemia upregulated HIF-1α, VEGF, and VEGFR2, effects abolished by DDMS and 6,15-20-HEDGE.
• ERK1/2 activation was identified as a downstream mediator of 20-HETE in ischemic angiogenesis.

Conclusions:

• 20-HETE is a critical mediator of ischemia-induced angiogenesis.
• 20-HETE regulates key angiogenic pathways including HIF-1α and VEGF signaling.
• Targeting 20-HETE may offer therapeutic strategies for peripheral ischemia.